发明名称 Liposomal formulation of irinotecan
摘要 The present invention is for novel compositions and methods for treating cancer, particularly, for treating cancer in mammals and more particularly in humans. The therapeutic compositions of the present invention include liposome entrapped irinotecan in which the liposome can contain any of a variety of neutral or charged liposome-forming compounds and cardiolipin. The liposomes of the present invention can be either multilamellar vesicles and unilamellar vesicles, as desired.
申请公布号 US7122553(B2) 申请公布日期 2006.10.17
申请号 US20030717378 申请日期 2003.11.19
申请人 NEOPHARM, INC. 发明人 RAHMAN AQUILUR;AHMAD IMRAN
分类号 A61K9/127;A61K31/436;A61K31/685;A61K47/14;C07D491/22 主分类号 A61K9/127
代理机构 代理人
主权项
地址